Hedgehog signaling in the liver

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Date of download: 6/21/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. The hedgehog (Hh) signaling—a proliferative pathway especially.
Thymocyte development summary
Angiogenesis and hepatocellular carcinoma
Volume 59, Issue 5, Pages (November 2013)
Cellular and Molecular Mechanisms of Liver Injury
Immunotherapy of hepatocellular carcinoma
Volume 18, Issue 6, Pages R238-R241 (March 2008)
Figure 3 Extracellular stimuli to HSC activation
Hepcidin in human iron disorders: Therapeutic implications
Volume 47, Issue 1, Pages (July 2007)
Liver regeneration Journal of Hepatology
Cellular and Molecular Mechanisms of Liver Injury
The function of serotonin within the liver
Erythropoietin neuroprotection with traumatic brain injury
Jan-Hendrik B. Hardenberg, Andrea Braun, Michael P. Schön 
Figure 2 Signalling molecules and pathways involved in HSC activation
Histamine regulation of biliary proliferation
Is Hepatitis C Virus Carcinogenic?
Daniel A. Langer, Vijay H. Shah  Journal of Hepatology 
Volume 56, Issue 3, Pages (March 2012)
Roles for Chemokines in Liver Disease
Liver Renewal: Detecting Misrepair and Optimizing Regeneration
Biology of the immunomodulatory molecule HLA-G in human liver diseases
Volume 66, Issue 2, Pages (February 2017)
Volume 136, Issue 1, Pages e2 (January 2009)
ChREBP in NASH – A liver transcription factor comes in from the cold
Inflammation and portal hypertension – The undiscovered country
Volume 148, Issue 7, Pages (June 2015)
From immunosuppression to tolerance
Hypoxia inducible factors in liver disease and hepatocellular carcinoma: Current understanding and future directions  Garrick K. Wilson, Daniel A. Tennant,
Volume 59, Issue 5, Pages (November 2013)
Signalling pathways in alcohol-induced liver inflammation
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
Targeting gut flora to prevent progression of hepatocellular carcinoma
Mechanisms of iron hepatotoxicity
Hedgehog Signaling: Is Smo a G Protein-Coupled Receptor?
Angiogenesis and hepatocellular carcinoma
Sumoylation Stabilizes Smoothened to Promote Hedgehog Signaling
Inhibition of mammalian target of rapamycin: Two goals with one shot?
Michael J. Williams, Andrew D. Clouston, Stuart J. Forbes 
Volume 59, Issue 3, Pages (September 2013)
Obesity, Inflammation, and Insulin Resistance
Met as a therapeutic target in HCC: Facts and hopes
Volume 70, Issue 7, Pages (October 2006)
Volume 66, Issue 1, Pages (January 2017)
Cannabinoid signaling and liver therapeutics
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
Death receptor-mediated apoptosis and the liver
Diarmaid Dominic Houlihan, Philip Noel Newsome  Gastroenterology 
NASH animal models: Are we there yet?
Salvatore Papa, Concetta Bubici  Journal of Hepatology 
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
How Bad Is the Hedgehog? GLI-Dependent, Hedgehog-Independent Cancers on the Importance of Biomarkers for Proper Patients Selection  Delphine Javelaud,
Macrophage heterogeneity in liver injury and fibrosis
The Expanding Cosmos of Nuclear Receptor Coactivators
Autophagy in liver diseases: Time for translation?
Silvia Affò, Ramón Bataller  Journal of Hepatology 
Tatiana Kisseleva, David A. Brenner  Journal of Hepatology 
Molecular mechanism of PPARα action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease  Michal Pawlak,
Michael J. Clague, Han Liu, Sylvie Urbé  Developmental Cell 
Smoothing Out Drug Resistance
Volume 18, Issue 6, Pages R238-R241 (March 2008)
GPC5 Gene and Its Related Pathways in Lung Cancer
EpCAM in hepatocytes and their progenitors
Treating myocardial ischemia-reperfusion injury by targeting endothelial cell transcription  Edward M Boyle, MD, Timothy G Canty, MD, Elizabeth N Morgan,
Foxa1 and Foxa2 regulate bile duct development in mice
Volume 119, Issue 4, Pages (October 2000)
Platelets arrive at the scene of fibrosis……studies
Macrophages, Immunity, and Metabolic Disease
Presentation transcript:

Hedgehog signaling in the liver Alessia Omenetti, Steve Choi, Gregory Michelotti, Anna Mae Diehl  Journal of Hepatology  Volume 54, Issue 2, Pages 366-373 (February 2011) DOI: 10.1016/j.jhep.2010.10.003 Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Hedgehog signaling. (A) Hh pathway is silent in Hh-responsive cells when Hh ligands are absent. Cells which are capable of responding to Hh ligands (i.e., Hh-responsive cells) express Hh receptors. Patched (Ptc) is the receptor that physically interacts with Hh ligands. In the absence of Hh ligands, Ptc represses the activation of a co-receptor-like molecule, Smoothened (Smo). This repression prevents Smo from interacting with other intracellular factors that permit the stabilization and accumulation of Glioblastoma (Gli) transcription factors. Thus, Gli proteins undergo phosphorylation by various intracellular kinases (PKA, GSK3β, CSK), become ubiquitinated, move to proteasomes, and are degraded. Reduced availability of Gli factors influences the transcription of their target genes. Lack of Gli1 and Gli2 generally reduces target gene transcription, while lack of Gli3 can either stimulate or inhibit transcriptional activity. (B) Hh ligands activate Hh pathway signaling. Interaction between Hh ligands and Ptc liberates Smoothened from the normal repressive actions of Ptc. This results in eventual inhibition of factors that promote Gli phosphorylation/degradation, and permits cellular accumulation of Gli. Other factors that inhibit Gli-phosphorylation, such as insulin-like growth factor-1 (IGF), have also been shown to facilitate stabilization of Gli1 in cells that are otherwise capable of producing this protein. There is also a report that Transforming Growth Factor beta (TGFβ) can stimulate Gli accumulation via mechanisms that may operate independently of Smoothened. Nuclear accumulation of Gli factors, in turn, influences transcriptional activity of Gli-target genes. Gli1 and Gli2 generally increase gene transcription, while Gli3 can either increase or decrease gene transcription depending on its post-translational modification. Journal of Hepatology 2011 54, 366-373DOI: (10.1016/j.jhep.2010.10.003) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Differential activity of the Hedgehog pathway in healthy and injured livers. (A) Healthy livers express low levels of Hedgehog (Hh) ligands. Several types of resident liver cells are capable of producing Hh ligands, including hepatocytes, cholangiocytes, hepatic stellate cells (HSC), natural killer T (NKT) cells, and sinusoidal endothelial cells. Ligand production can be stimulated by growth factors/cytokines, as well as by cytotoxic/apoptotic stress. Thus, diverse stimuli that promote liver regeneration/remodeling induce hepatic production of Hh ligands. (B) Healthy livers express low levels of Hh ligands (a) and relatively high levels of Hh interacting protein (Hhip) (b), which binds to Hh ligands, preventing them from engaging receptors on Hh-responsive target cells. During liver injury, production of Hh ligands increases (Fig. 2A) and Hhip is repressed, permitting ligand-receptor interaction and activation of the Hh signaling pathway in Hh-responsive cells. The latter includes several types of resident liver cells, including NKT cells, cholangiocytes, progenitors and quiescent hepatic stellate cells (Q-HSC). Activation of Hh signaling in each of these cell types induces responses that contribute to fibrogenic repair. For example, Hh pathway activation stimulates growth of NKT cell populations and induces their production of pro-fibrogenic factors, such as IL4 and IL13. It also stimulates cholangiocyte growth and production of chemokines, including chemokines that recruit NKT cells and other inflammatory/immune cells to the liver. In addition, Hh ligands promote growth of liver progenitors and stimulate Q-HSC to transition to become myofibroblastic (MF)-HSC. The growth of MF-HSC is further stimulated by Hh pathway activity. Coupled with expansion of Hh-responsive ductular and progenitor populations, this contributes to the fibroductular reaction that often accompanies liver injury. Finally, Hh ligands activate liver sinusoidal endothelial cells, causing them to express adhesion factors and other mediators that contribute to vascular remodeling. Journal of Hepatology 2011 54, 366-373DOI: (10.1016/j.jhep.2010.10.003) Copyright © 2010 European Association for the Study of the Liver Terms and Conditions